These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 23170994)
1. Peptido sulfonyl fluorides as new powerful proteasome inhibitors. Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994 [TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides. Brouwer AJ; Herrero Álvarez N; Ciaffoni A; van de Langemheen H; Liskamp RM Bioorg Med Chem; 2016 Aug; 24(16):3429-35. PubMed ID: 27316540 [TBL] [Abstract][Full Text] [Related]
3. Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors. Rydzewski RM; Burrill L; Mendonca R; Palmer JT; Rice M; Tahilramani R; Bass KE; Leung L; Gjerstad E; Janc JW; Pan L J Med Chem; 2006 May; 49(10):2953-68. PubMed ID: 16686537 [TBL] [Abstract][Full Text] [Related]
4. Potential peptidic proteasome inhibitors by incorporation of an electrophilic trap based on amino acid derived α-substituted sulfonyl fluorides. Herrero Alvarez N; van de Langemheen H; Brouwer AJ; Liskamp RMJ Bioorg Med Chem; 2017 Oct; 25(19):5055-5063. PubMed ID: 28734665 [TBL] [Abstract][Full Text] [Related]
6. Mixing of peptides and electrophilic traps gives rise to potent, broad-spectrum proteasome inhibitors. Verdoes M; Florea BI; van der Linden WA; Renou D; van den Nieuwendijk AM; van der Marel GA; Overkleeft HS Org Biomol Chem; 2007 May; 5(9):1416-26. PubMed ID: 17464411 [TBL] [Abstract][Full Text] [Related]
8. Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides. Artschwager R; Ward DJ; Gannon S; Brouwer AJ; van de Langemheen H; Kowalski H; Liskamp RMJ J Med Chem; 2018 Jun; 61(12):5395-5411. PubMed ID: 29782167 [TBL] [Abstract][Full Text] [Related]
9. Development of peptidomimetic boronates as proteasome inhibitors. Micale N; Ettari R; Lavecchia A; Di Giovanni C; Scarbaci K; Troiano V; Grasso S; Novellino E; Schirmeister T; Zappalà M Eur J Med Chem; 2013 Jun; 64():23-34. PubMed ID: 23639651 [TBL] [Abstract][Full Text] [Related]
10. Modulation of proteasome subunit selectivity of syringolins. Tatsumi K; Kitahata S; Komatani Y; Katsuyama A; Yakushiji F; Ichikawa S Bioorg Med Chem; 2024 May; 106():117733. PubMed ID: 38704960 [TBL] [Abstract][Full Text] [Related]
11. Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome. Desvergne A; Genin E; Maréchal X; Gallastegui N; Dufau L; Richy N; Groll M; Vidal J; Reboud-Ravaux M J Med Chem; 2013 Apr; 56(8):3367-78. PubMed ID: 23540790 [TBL] [Abstract][Full Text] [Related]
12. Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action. Kawamura S; Unno Y; List A; Mizuno A; Tanaka M; Sasaki T; Arisawa M; Asai A; Groll M; Shuto S J Med Chem; 2013 May; 56(9):3689-700. PubMed ID: 23547757 [TBL] [Abstract][Full Text] [Related]
13. Indolo-phakellins as β5-specific noncovalent proteasome inhibitors. Beck P; Lansdell TA; Hewlett NM; Tepe JJ; Groll M Angew Chem Int Ed Engl; 2015 Feb; 54(9):2830-3. PubMed ID: 25581903 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and docking studies of novel dipeptidyl boronic acid proteasome inhibitors constructed from αα- and αβ-amino acids. Shi J; Lei M; Wu W; Feng H; Wang J; Chen S; Zhu Y; Hu S; Liu Z; Jiang C Bioorg Med Chem Lett; 2016 Apr; 26(8):1958-62. PubMed ID: 26965867 [TBL] [Abstract][Full Text] [Related]
15. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells. Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the 26S proteasome by peptide mimics of the coiled-coil region of its ATPase subunits. Inobe T; Genmei R Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):143-50. PubMed ID: 26522225 [TBL] [Abstract][Full Text] [Related]
17. Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i). Klein M; Busch M; Friese-Hamim M; Crosignani S; Fuchss T; Musil D; Rohdich F; Sanderson MP; Seenisamy J; Walter-Bausch G; Zanelli U; Hewitt P; Esdar C; Schadt O J Med Chem; 2021 Jul; 64(14):10230-10245. PubMed ID: 34228444 [TBL] [Abstract][Full Text] [Related]
18. Discovery of a potent and highly specific β Zhou T; Cai Y; Liang L; Yang L; Xu F; Niu Y; Wang C; Zhang JL; Xu P Bioorg Med Chem Lett; 2016 Dec; 26(23):5780-5784. PubMed ID: 27816516 [TBL] [Abstract][Full Text] [Related]
19. Inhibitors for the immuno- and constitutive proteasome: current and future trends in drug development. Huber EM; Groll M Angew Chem Int Ed Engl; 2012 Aug; 51(35):8708-20. PubMed ID: 22711561 [TBL] [Abstract][Full Text] [Related]
20. Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits. Hovhannisyan AA; Pham TH; Bouvier D; Tan X; Touhar S; Mkryan GG; Dallakyan AM; El Amri C; Melikyan GS; Reboud-Ravaux M; Bouvier-Durand M Bioorg Med Chem Lett; 2017 Dec; 27(23):5172-5178. PubMed ID: 29113763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]